INCB001158 Combined With Subcutaneous (SC) Daratumumab, Compared to Daratumumab SC, in Relapsed or Refractory Multiple Myeloma

Last updated: N/A
Sponsor: N/A
Overall Status: Active - Recruiting

Phase

1/2

Condition

Multiple Myeloma

Treatment

N/A

Clinical Study ID

TX225647
  • Ages 18-100
  • All Genders

Study Summary

The purpose of this study is to evaluate the safety and antitumor activity of INCB001158 in combination with daratumumab SC, compared with daratumumab SC alone, in participants with relapsed or refractory multiple myeloma who have received at least 3 but not more than 5 prior lines of multiple myeloma therapy.

Eligibility Criteria

Inclusion

Additonal Conditions:

  • Relapsed or Refractory Multiple Myeloma
  • Relapsed Multiple Myeloma
  • Refractory Multiple Myeloma

Study Design

Study Start date:
Estimated Completion Date:

Study Description

Connect with a study center

  • UNIVERSITY OF HEIDELBERG

    Heidelberg, Heidelberg 69117
    Germany

    Active - Recruiting

  • UNIVERSITÄTSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITÄT MAINZ, III

    MAINZ, MAINZ 55131
    Germany

    Active - Recruiting

  • Hospital General Universitari Vall D Hebron

    Barcelona, 08035
    Spain

    Active - Recruiting

  • HOSPITAL CLINICO UNIVERSITARIO DE SALAMANCA

    Salamanca, 37007
    Spain

    Active - Recruiting

  • Hospital Universitario Marques De Valdecilla

    Santander, 39008
    Spain

    Active - Recruiting

  • HOSPITAL DURAN I REYNALS

    Barcelona, Barcelona 08908
    Spain

    Active - Recruiting

  • HOSPITAL UNIVERSITARIO 12 DE OCTUBRE

    MADRID, MADRID 28041
    Spain

    Active - Recruiting

  • Hospital Universitario Ramon Y Cajal

    Madrid, Madrid 28034
    Spain

    Active - Recruiting

  • CLINICA UNIVERSIDAD DE NAVARRA (CUN)

    Pamplona, Pamplona 31003
    Spain

    Active - Recruiting

  • HOSPITAL UNIVERSITARI Y POLITECNIC LA FE

    Valencia, Valencia 46026
    Spain

    Active - Recruiting

  • Hospital Universitario Dr. Peset

    Valencia, Valencia 46017
    Spain

    Active - Recruiting

  • SOUTHERN CANCER CENTER

    Daphne, Alabama 36526
    United States

    Active - Recruiting

  • ARIZONA ONCOLOGY ASSOCIATES (WILMOT)

    Tucson, Arizona 85711
    United States

    Active - Recruiting

  • ROCKY MOUNTAIN CANCER CENTER

    Denver, Colorado 80218
    United States

    Active - Recruiting

  • Dana Farber Cancer Institute

    Boston, Massachusetts 02215
    United States

    Active - Recruiting

  • Massachusetts General Hospital

    Boston, Massachusetts 02114
    United States

    Active - Recruiting

  • Comprehensive Cancer Center of Nevada

    Las Vegas, Nevada 89169
    United States

    Active - Recruiting

  • NEW YORK ONCOLOGY HEMATOLOGY

    Albany, New York 12206
    United States

    Active - Recruiting

  • LINEBERGER COMPREHENSIVE CANCER CENTER AT UNIVERSITY OF NORTH CAROLINA CHAPEL HILL

    Chapel Hill, North Carolina 27514
    United States

    Active - Recruiting

  • ONCOLOGY HEMATOLOGY CARE, INC

    Cincinnati, Ohio 45236
    United States

    Active - Recruiting

  • TEXAS ONCOLOGY-AUSTIN MIDTOWN

    Austin, Texas 78705
    United States

    Active - Recruiting

  • TEXAS ONCOLOGY - FORT WORTH SOUTH HENDERSON

    Fort Worth, Texas 76104
    United States

    Active - Recruiting

  • Texas Oncology - San Antonio

    San Antonio, Texas 78240
    United States

    Active - Recruiting

  • TEXAS ONCOLOGY - TYLER

    Tyler, Texas 75702
    United States

    Active - Recruiting

  • UNIVERSITY OF VIRGINIA

    Charlottesville, Virginia 22908
    United States

    Active - Recruiting

  • VIRGINIA CANCER SPECIALISTS-FAIRFAX

    Fairfax, Virginia 22031
    United States

    Active - Recruiting

  • FUNDACION JIMENEZ DIAZ UNIVERSITY HOSPITAL

    MADRID, 28040

    Active - Recruiting

  • HOSPITAL CLINIC DE BARCELONA

    BARCELONA, BARCELONA 08036

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.